Xanthus Pharmaceuticals Overview
- Year Founded
-
2001
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$52.9M
Xanthus Pharmaceuticals General Information
Description
Developer of small-molecule therapeutics for the treatment of cancer and autoimmune disorders.
Contact Information
Website
www.xanthus.comCorporate Office
- 300 Technology Square
- Cambridge, MA 02139
- United States
Corporate Office
- 300 Technology Square
- Cambridge, MA 02139
- United States
Xanthus Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Merger/Acquisition | 11-Jun-2008 | $52.9M | Completed | Generating Revenue | ||
| 4. Later Stage VC | 07-Mar-2008 | Completed | Generating Revenue | |||
| 3. Later Stage VC | 30-Nov-2006 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 12-Dec-2003 | $30.8M | $42.8M | Completed | Product Development | |
| 1. Early Stage VC | 31-Dec-2001 | $12M | $12M | Completed | Product Development |
Xanthus Pharmaceuticals Former Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| CDIB BioScience Venture Management | Venture Capital | Minority | ||
| CDIB Capital Group | Asset Manager | Minority | ||
| GeneChem | Venture Capital | Minority | ||
| Gimv | PE/Buyout | Minority | ||
| HealthCare Ventures | Venture Capital | Minority |
Xanthus Pharmaceuticals FAQs
-
When was Xanthus Pharmaceuticals founded?
Xanthus Pharmaceuticals was founded in 2001.
-
Where is Xanthus Pharmaceuticals headquartered?
Xanthus Pharmaceuticals is headquartered in Cambridge, MA.
-
What industry is Xanthus Pharmaceuticals in?
Xanthus Pharmaceuticals’s primary industry is Drug Discovery.
-
Is Xanthus Pharmaceuticals a private or public company?
Xanthus Pharmaceuticals is a Private company.
-
What is the current valuation of Xanthus Pharmaceuticals?
The current valuation of Xanthus Pharmaceuticals is .
-
What is Xanthus Pharmaceuticals’s current revenue?
The current revenue for Xanthus Pharmaceuticals is .
-
How much funding has Xanthus Pharmaceuticals raised over time?
Xanthus Pharmaceuticals has raised $83.8M.
-
Who are Xanthus Pharmaceuticals’s investors?
CDIB BioScience Venture Management, CDIB Capital Group, GeneChem, Gimv, and HealthCare Ventures are 5 of 12 investors who have invested in Xanthus Pharmaceuticals.
-
When was Xanthus Pharmaceuticals acquired?
Xanthus Pharmaceuticals was acquired on 11-Jun-2008.
-
Who acquired Xanthus Pharmaceuticals?
Xanthus Pharmaceuticals was acquired by Sarossa Capital.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process